The Journal of Immunology, Vol 147, Issue 12 4167-4171, Copyright © 1991 by American Association of Immunologists

ARTICLES

ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats

Y Iigo, T Takashi, T Tamatani, M Miyasaka, T Higashida, H Yagita, K Okumura and W Tsukada
Exploratory Research Laboratory 3, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.

Intercellular adhesion molecule 1 (ICAM-1) plays important roles in immune responses. In order to examine whether ICAM-1 is involved in pathogenesis of adjuvant arthritis (AA), we investigated the effect of anti-ICAM-1 mAb, 1A29, on AA in rats. In vivo administration of 1A29 exerted a very strong suppressive effect on the development of arthritis and induced a marked reduction of inflammatory parameters. 1A29 suppressed the Ag-specific proliferative response of lymph node cells from AA rats, suggesting that the mAb blocked the Ag recognition phase. The study using adoptive transfer of AA revealed that 1A29 completely inhibited production of arthritogenic lymphocytes in donors and partially suppressed progression of arthritis in recipients caused by these lymphocytes. These findings indicated that the inhibitory effect of 1A29 on development of arthritis was at least twofold, i.e., 1) interference with cell-cell interaction between APC and T cells, which resulted in abrogation of effector cell generation; and 2) blocking of effector cell migration to inflammatory lesions. These results indicated that ICAM-1-dependent pathway is critically involved in the pathogenesis of AA. The data support the concept that ICAM-1- dependent pathways are important in chronic inflammatory disease.

This article has been cited by other articles:

				S. Karatay, A. Kiziltunc, K. Yildirim, R. C. Karanfil, and K. Senel Effects of Different Hyaluronic Acid Products on Synovial Fluid Levels of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Knee Osteoarthritis Ann. Clin. Lab. Sci., July 1, 2004; 34(3): 330 - 335. [Abstract] [Full Text] [PDF]

				F. Kuwahara, H. Kai, K. Tokuda, H. Niiyama, N. Tahara, K. Kusaba, K. Takemiya, A. Jalalidin, M. Koga, T. Nagata, et al. Roles of Intercellular Adhesion Molecule-1 in Hypertensive Cardiac Remodeling Hypertension, March 1, 2003; 41(3): 819 - 823. [Abstract] [Full Text] [PDF]

				H. Machelska, S. A. Mousa, A. Brack, J. K. Schopohl, H. L. Rittner, M. Schafer, and C. Stein Opioid Control of Inflammatory Pain Regulated by Intercellular Adhesion Molecule-1 J. Neurosci., July 1, 2002; 22(13): 5588 - 5596. [Abstract] [Full Text] [PDF]

				F. Zeni, C. Parent, R. Correa, C. Natanson, B. Freeman, J. Fontana, M. Quezado, R. L. Danner, Y. Fitz, S. Richmond, et al. ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia J Appl Physiol, July 1, 1999; 87(1): 299 - 307. [Abstract] [Full Text] [PDF]

				C. G. Feng, A. G. D. Bean, H. Hooi, H. Briscoe, and W. J. Britton Increase in Gamma Interferon-Secreting CD8+, as Well as CD4+, T Cells in Lungs following Aerosol Infection with Mycobacterium tuberculosis Infect. Immun., July 1, 1999; 67(7): 3242 - 3247. [Abstract] [Full Text] [PDF]

				D. S. Kim, S. H. Paik, C. M. Lim, S. D. Lee, Y. Koh, W. S. Kim, and W. D. Kim Value of ICAM-1 Expression and Soluble ICAM-1 Level as a Marker of Activity in Sarcoidosis Chest, April 1, 1999; 115(4): 1059 - 1065. [Abstract] [Full Text] [PDF]

				Y. Tominaga, Y. Kita, A. Satoh, S. Asai, K. Kato, K. Ishikawa, T. Horiuchi, and T. Takashi Affinity and Kinetic Analysis of the Molecular Interaction of ICAM-1 and Leukocyte Function-Associated Antigen-1 J. Immunol., October 15, 1998; 161(8): 4016 - 4022. [Abstract] [Full Text] [PDF]

				H. Harada, T. Kukita, A. Kukita, Y. Iwamoto, and T. Iijima Involvement of Lymphocyte Function-Associated Antigen-1 and Intercellular Adhesion Molecule-1 in Osteoclastogenesis: A Possible Role in Direct Interaction between Osteoclast Precursors Endocrinology, September 1, 1998; 139(9): 3967 - 3975. [Abstract] [Full Text] [PDF]

				J. M. Glover, J. M. Leeds, T. G. K. Mant, D. Amin, D. L. Kisner, J. E. Zuckerman, R. S. Geary, A. A. Levin, and W. R. Shanahan Jr. Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302) J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1173 - 1180. [Abstract] [Full Text]

				J. W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen Novel Inhibitors of Cytokine-induced Ikappa Balpha Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo J. Biol. Chem., August 22, 1997; 272(34): 21096 - 21103. [Abstract] [Full Text] [PDF]

				H. Yasukawa, T. Imaizumi, H. Matsuoka, A. Nakashima, and M. Morimatsu Inhibition of Intimal Hyperplasia After Balloon Injury by Antibodies to Intercellular Adhesion Molecule-1 and Lymphocyte Function–Associated Antigen-1 Circulation, March 18, 1997; 95(6): 1515 - 1522. [Abstract] [Full Text]